Login / Signup

Floating Epoch Length Improves the Accuracy of Accelerometry-Based Estimation of Coincident Oxygen Consumption.

Henri Vähä-YpyäPauliina HusuTommi VasankariHarri Sievänen
Published in: Sensors (Basel, Switzerland) (2023)
Estimation of oxygen consumption (VO 2 ) from accelerometer data is typically based on prediction equations developed in laboratory settings using steadily paced and controlled test activities. These equations may not capture the temporary changes in VO 2 occurring in sporadic real-life physical activity. In this study, we introduced a novel floating epoch for accelerometer data analysis and hypothesized that an adaptive epoch length provides a more consistent estimation of VO 2 in irregular activity conditions than a 6 s constant epoch. Two different activity tests were conducted: a progressive constant-speed test (CS) performed on a track and a 6 min back-and-forth walk test including accelerations and decelerations (AC/DC) performed as fast as possible. Twenty-nine adults performed the CS test, and sixty-one performed the AC/DC test. The data were collected using hip-worn accelerometers and a portable metabolic gas analyzer. General linear models were employed to create the prediction models for VO 2 that were cross-validated using both data sets and epoch types as training and validation sets. The prediction equations based on the CS test or AC/DC test and 6 s epoch had excellent performance (R 2 = 89%) for the CS test but poor performance for the AC/DC test (31%). Only the VO 2 prediction equation based on the AC/DC test and the floating epoch had good performance (78%) for both tests. The overall accuracy of VO 2 prediction is compromised with the constant length epoch, whereas the prediction model based on irregular acceleration data analyzed with a floating epoch provided consistent performance for both activities.
Keyphrases
  • physical activity
  • data analysis
  • dendritic cells
  • electronic health record
  • big data
  • multiple sclerosis
  • body mass index
  • amyotrophic lateral sclerosis
  • carbon dioxide